Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NMDA glutamate receptor is an ionotropic glutamate receptor subtype that mediates excitatory neurotransmission in the central nervous system. It is a heterotetrameric complex typically composed of GluN1 and GluN2 (or GluN3) subunits. Activation requires the binding of glutamate and glycine (or D-serine) and the relief of Mg²⁺ block via membrane depolarization. It plays a crucial role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders due to its involvement in excitotoxicity.
Ligand-gated ion channel activation; glutamate and glycine/D-serine binding, channel opening, ion flux (Ca²⁺, Na⁺, K⁺); voltage-dependent Mg²⁺ block relief.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NMDA glutamate receptor (NMDAR).